Skip to main content
Premium Trial:

Request an Annual Quote

Michael Stapleton, Vivien Bonazzi, Tom Schwei, PanVera

Premium

Invitrogen has named Michael Stapleton general manager and vice president of its bioinformatics business and Vivien Bonazzi director of R&D for bioinformatics. Both positions “exemplify Invitrogen’s commitment to making bioinformatics an integral part of its solution set for life science research,” the company said in a statement. Stapleton most recently served as executive vice president and chief operating officer of Accelrys. Bonazzi was director of product development and scientific management at Celera Genomics before joining Invitrogen.


DNAStar has hired Tom Schwei as vice president and general manager. Schwei has held management positions at

Promega

, PanVera, and Invitrogen.

 

Filed under

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.